Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients

Philippe Halfon, Guillaume Penaranda, Denis Ouzan, Patrick Philibert, Hacène Khiri, Sofiane Mohamed

Open source

DOI
10.1016/s2055-6640(20)30363-0
Published
05
Container
Journal of Virus Eradication
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2055-6640-20-30363-0,
  title = {Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients},
  author = {Philippe Halfon and Guillaume Penaranda and Denis Ouzan and Patrick Philibert and Hacène Khiri and Sofiane Mohamed},
  year = {2018},
  journal = {Journal of Virus Eradication},
  doi = {10.1016/s2055-6640(20)30363-0},
  url = {https://doi.org/10.1016/s2055-6640(20)30363-0}
}

RIS

TY  - JOUR
TI  - Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients
AU  - Philippe Halfon
AU  - Guillaume Penaranda
AU  - Denis Ouzan
AU  - Patrick Philibert
AU  - Hacène Khiri
AU  - Sofiane Mohamed
PY  - 2018
JO  - Journal of Virus Eradication
DO  - 10.1016/s2055-6640(20)30363-0
UR  - https://doi.org/10.1016/s2055-6640(20)30363-0
ER  - 

APA

Halfon, P., Penaranda, G., Ouzan, D., Philibert, P., Khiri, H., & Mohamed, S. (2018). Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients. Journal of Virus Eradication. https://doi.org/10.1016/s2055-6640(20)30363-0

Source records